Skip to main content
Veterinary Medicines

CRYOMAREX HVT

Not authorised
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live

Product identification

Medicine name:
CRYOMAREX HVT
Active substance:
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Target species:
  • Chicken (one day-old chick)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
    3.00
    log10 plaque forming unit(s)
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (one day-old chick)
      • All relevant tissues
        0
        day
  • Subcutaneous use
    • Chicken (one day-old chick)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5332435 9/1985
Date of authorisation status change:

Documents

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 5/07/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."